News about our Companies - MedTech Innovator

GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium

DateAug 05 2019

Munich, Germany, August 5, 2019 – GNA Biosolutions GmbH, a molecular diagnostics company based in Germany, announced today that it has completed a $13.5M round of...

Bigfoot Biomedical Announces Partnership with Allegheny Health Network to Advance Innovative Solution for People with Diabetes

DateAug 01 2019

Milpitas, CA, and Pittsburgh, PA, August 1, 2019 – Bigfoot Biomedical, Inc., and Allegheny Health Network (AHN) – a Highmark Health company – announced today a...

Israeli companies chosen for MedTech Innovator Showcase

DateJul 22 2019

Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants. Israeli biomed companies Medasense and...

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

DateJul 22 2019

NEW YORK, July 22, 2019 /PRNewswire/ — Nanowear, the leading nanotechnology-based connected-care and remote monitoring platform, today announced the clinical launch of NanoSENSE, a Heart Failure Management...

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

DateJul 15 2019

LISLE, Ill., July 15, 2019 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first...

Centerline Biomedical Receives FDA 510(k) Clearance for Intra-Operative Positioning System

DateJul 11 2019

Centerline Biomedical, Inc. has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship...

Emovi Announces U.S. Commercial Launch of KneeKG In-Clinic Device

DateJul 11 2019

Emovi Inc. has announced the U.S. launch of KneeKG, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable...

Day Zero Diagnostics Awarded Phase I SBIR Grant for Algorithm Development

DateJul 10 2019

Day Zero Diagnostics (DZD) said today it has received a Phase I Small Business Innovation Research (SBIR) award from the NIH’s National Institute of Allergies...